Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Phase I study results reported for TP10 in AMI

March 31, 1998

Toyama researchers characterize antiplatelet/antithrombotic effects of T-250

March 31, 1998

Pharmacological profile of new PDE V inhibitor from Eisai

March 31, 1998

Green tea extract shows potent chemopreventive activity in vitro

March 31, 1998

Role of protease inhibitors in chemotherapy explored at AACR meeting

March 31, 1998

U.S. universities develop new agents for PCP

March 30, 1998

NC-100100 enhances myocardial infarction imaging in dogs

March 30, 1998

Excitatory amino acid receptor antagonists related to PNQX reported at ACS

March 30, 1998

Platelet antiaggregatory effects of liposome-encapsulated streptokinase

March 30, 1998

Z-335 demonstrates beneficial effects in models of peripheral circulatory insufficiency

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...